Home ETF List About

Portfolio Holdings Detail for ISIN IE00BYXG2H39
Stock Name / FundiShares Nasdaq US Biotechnology UCITS ETF USD (Acc)
IssuerBlackrock
Entity holding fund iShares IV Public Limited Company
Entity TypeUmbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300ZP07LMR36K1T02
ETF TickerBTEC(USD) LSE
ETF TickerBTEK(GBP) LSE
ETF Ticker2B70(EUR) F
ETF Ticker2B70.DE(EUR) CXE
ETF TickerBTEC.LS(USD) CXE
ETF TickerBTEK.LS(GBP) CXE
ETF TickerBTEC.L(GBP) LSE
ETF TickerBTEK.L(GBP) LSE

Holdings detail for INSM

Stock NameInsmed Inc
TickerINSM(USD) NASDAQ
TYPECommon Stock
CountryUSA
ISINUS4576693075
LEI529900Q55QAG41CCAC11

Show aggregate INSM holdings

News associated with INSM

Analysts Set Insmed, Inc. (NASDAQ:INSM) Price Target at $139.86
Insmed, Inc. (NASDAQ:INSM – Get Free Report) has been assigned an average rating of “Moderate Buy” from the seventeen brokerages that are covering the firm, MarketBeat.com reports. One research analyst has rated the stock with a hold recommendation and sixteen have assigned a buy recommendation to the company. The average 1-year target price among brokerages […] - 2025-09-17 02:58:45
Insmed (NASDAQ:INSM) Reaches New 12-Month High on Analyst Upgrade
Shares of Insmed, Inc. (NASDAQ:INSM – Get Free Report) hit a new 52-week high on Monday after Guggenheim raised their price target on the stock from $125.00 to $172.00. Guggenheim currently has a buy rating on the stock. Insmed traded as high as $146.91 and last traded at $145.86, with a volume of 288114 shares […] - 2025-09-10 02:26:50
Top Analyst Reports for Microsoft, Amazon.com & Philip Morris
Microsoft, Amazon.com and Philip Morris headline fresh analyst reports highlighting AI, cloud, and smoke-free growth momentum. - 2025-09-05 18:11:00
Notable ETF Outflow Detected - XBI, ALNY, HALO, INSM
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an approximate $119.6 million dollar outflow -- that's a 2.2% decrease week over week - 2025-08-28 11:56:11
Insmed (NASDAQ:INSM) Earns Outperform Rating from Analysts at William Blair
Stock analysts at William Blair initiated coverage on shares of Insmed (NASDAQ:INSM – Get Free Report) in a research note issued on Wednesday, MarketBeat Ratings reports. The firm set an “outperform” rating on the biopharmaceutical company’s stock. Other research analysts also recently issued reports about the stock. Truist Financial upped their target price on shares […] - 2025-08-22 02:54:45
IMCB's Underlying Holdings Could Mean 12% Gain Potential
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-08-18 09:44:41
The Goldman Sachs Group Forecasts Strong Price Appreciation for Insmed (NASDAQ:INSM) Stock
Insmed (NASDAQ:INSM – Get Free Report) had its target price increased by equities researchers at The Goldman Sachs Group from $114.00 to $142.00 in a research note issued to investors on Wednesday,Benzinga reports. The firm currently has a “buy” rating on the biopharmaceutical company’s stock. The Goldman Sachs Group’s price target indicates a potential upside […] - 2025-08-15 07:10:57
INSM Crosses Above Average Analyst Target
In recent trading, shares of Insmed Inc (Symbol: INSM) have crossed above the average analyst 12-month target price of $119.12, changing hands for $122.00/share. When a stock reaches the target an analyst has set, the analyst logically has two ways to react: downgrade on valuati - 2025-08-13 10:41:52
Insmed (NASDAQ:INSM) Reaches New 1-Year High Following Analyst Upgrade
Insmed, Inc. (NASDAQ:INSM – Get Free Report)’s share price hit a new 52-week high during mid-day trading on Monday after Wells Fargo & Company raised their price target on the stock from $119.00 to $130.00. Wells Fargo & Company currently has an overweight rating on the stock. Insmed traded as high as $113.41 and last […] - 2025-08-13 02:23:00
XBI, ALNY, INSM, INCY: Large Outflows Detected at ETF
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the SPDR S&P Biotech ETF (Symbol: XBI) where we have detected an approximate $202.3 million dollar outflow -- that's a 4.3% decrease week over week - 2025-08-12 11:55:54
Insmed, Inc. (NASDAQ:INSM) Shares Purchased by Charles Schwab Investment Management Inc.
Charles Schwab Investment Management Inc. raised its stake in shares of Insmed, Inc. (NASDAQ:INSM – Free Report) by 3.6% during the 1st quarter, Holdings Channel reports. The institutional investor owned 1,602,655 shares of the biopharmaceutical company’s stock after buying an additional 56,048 shares during the period. Charles Schwab Investment Management Inc.’s holdings in Insmed were […] - 2025-08-12 05:59:02
Mackenzie Financial Corp Acquires 2,220 Shares of Insmed, Inc. (NASDAQ:INSM)
Mackenzie Financial Corp lifted its holdings in Insmed, Inc. (NASDAQ:INSM – Free Report) by 20.4% in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 13,103 shares of the biopharmaceutical company’s stock after buying an additional 2,220 shares during the quarter. Mackenzie Financial Corp’s holdings in […] - 2025-08-06 05:07:44
Insmed, Inc. (NASDAQ:INSM) Shares Acquired by Cwm LLC
Cwm LLC grew its holdings in Insmed, Inc. (NASDAQ:INSM – Free Report) by 24.5% in the 1st quarter, HoldingsChannel.com reports. The fund owned 2,052 shares of the biopharmaceutical company’s stock after buying an additional 404 shares during the quarter. Cwm LLC’s holdings in Insmed were worth $157,000 as of its most recent SEC filing. Several […] - 2025-07-29 04:28:55
Allianz Asset Management GmbH Has $5.74 Million Holdings in Insmed, Inc. (NASDAQ:INSM)
Allianz Asset Management GmbH raised its stake in shares of Insmed, Inc. (NASDAQ:INSM – Free Report) by 4.9% in the first quarter, Holdings Channel.com reports. The firm owned 75,284 shares of the biopharmaceutical company’s stock after buying an additional 3,534 shares during the period. Allianz Asset Management GmbH’s holdings in Insmed were worth $5,743,000 as […] - 2025-07-28 05:46:50
Congress Trade: Representative Josh Gottheimer Just Disclosed New Stock Trades
Representative Josh Gottheimer just filed new stock trades, which we received from a STOCK Act disclosure. You can see the full list of trades on Quiver Quantitative's congress trading dashboard, and track the portfolios of Representative Josh Gottheimer and other politicians. - 2025-07-17 10:12:46
Insmed, Inc. (NASDAQ:INSM) Shares Bought by Xponance Inc.
Xponance Inc. boosted its stake in shares of Insmed, Inc. (NASDAQ:INSM – Free Report) by 5.3% during the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 13,359 shares of the biopharmaceutical company’s stock after buying an additional 670 shares during the period. Xponance Inc.’s holdings in Insmed […] - 2025-07-17 06:35:03
Envestnet Asset Management Inc. Grows Holdings in Insmed, Inc. (NASDAQ:INSM)
Envestnet Asset Management Inc. raised its position in Insmed, Inc. (NASDAQ:INSM – Free Report) by 26.9% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 325,307 shares of the biopharmaceutical company’s stock after purchasing an additional 68,949 shares during the quarter. Envestnet Asset Management […] - 2025-07-16 07:23:19
Sara Bonstein Sells 57,764 Shares of Insmed, Inc. (NASDAQ:INSM) Stock
Insmed, Inc. (NASDAQ:INSM – Get Free Report) CFO Sara Bonstein sold 57,764 shares of the company’s stock in a transaction on Monday, July 7th. The shares were sold at an average price of $95.86, for a total value of $5,537,257.04. Following the completion of the sale, the chief financial officer owned 84,017 shares in the […] - 2025-07-11 05:13:00
Teacher Retirement System of Texas Sells 2,654 Shares of Insmed, Inc. (NASDAQ:INSM)
Teacher Retirement System of Texas lessened its holdings in shares of Insmed, Inc. (NASDAQ:INSM – Free Report) by 5.5% during the 1st quarter, Holdings Channel.com reports. The firm owned 45,683 shares of the biopharmaceutical company’s stock after selling 2,654 shares during the period. Teacher Retirement System of Texas’ holdings in Insmed were worth $3,485,000 at […] - 2025-07-09 05:48:57
Brokerages Set Insmed, Inc. (NASDAQ:INSM) Target Price at $106.80
Shares of Insmed, Inc. (NASDAQ:INSM – Get Free Report) have earned an average rating of “Buy” from the seventeen brokerages that are presently covering the stock, MarketBeat Ratings reports. Seventeen equities research analysts have rated the stock with a buy recommendation. The average 12-month price target among brokers that have updated their coverage on the […] - 2025-07-04 02:40:47
Insmed, Inc. (NASDAQ:INSM) CFO Sara Bonstein Sells 57,765 Shares
Insmed, Inc. (NASDAQ:INSM – Get Free Report) CFO Sara Bonstein sold 57,765 shares of the stock in a transaction on Monday, June 23rd. The shares were sold at an average price of $101.78, for a total value of $5,879,321.70. Following the completion of the sale, the chief financial officer now owns 93,536 shares in the […] - 2025-06-27 05:06:55
Avior Wealth Management LLC Raises Holdings in Insmed, Inc. (NASDAQ:INSM)
Avior Wealth Management LLC lifted its holdings in shares of Insmed, Inc. (NASDAQ:INSM – Free Report) by 82.2% during the first quarter, according to its most recent disclosure with the SEC. The fund owned 4,151 shares of the biopharmaceutical company’s stock after acquiring an additional 1,873 shares during the period. Avior Wealth Management LLC’s holdings […] - 2025-06-23 05:12:58
Is Insmed Stock Overvalued at $98?
Insmed Inc (NASDAQ: INSM) was nothing short of a juggernaut last month, skyrocketing 45%, while the S&P500 index gained 3% during the same period. What’s fueling the fire? Insmed announced that its Phase IIb trial for treprostinil palmitil inhalation powder (TPIP) in pulmonar - 2025-06-17 03:35:22
Notable ETF Outflow Detected - IWO, SFM, INSM, FTAI
Looking today at week-over-week shares outstanding changes among the universe of ETFs covered at ETF Channel, one standout is the iShares Russell 2000 Growth ETF (Symbol: IWO) where we have detected an approximate $123.7 million dollar outflow -- that's a 1.1% decrease week ove - 2025-06-16 11:49:52
Insmed Incorporated (NASDAQ:INSM) CFO Sells $5,148,105.92 in Stock
Insmed Incorporated (NASDAQ:INSM – Get Free Report) CFO Sara Bonstein sold 57,766 shares of the company’s stock in a transaction on Tuesday, June 10th. The stock was sold at an average price of $89.12, for a total transaction of $5,148,105.92. Following the sale, the chief financial officer now directly owns 103,412 shares in the company, […] - 2025-06-16 05:18:57
Park Avenue Securities LLC Has $842,000 Holdings in Insmed Incorporated (NASDAQ:INSM)
Park Avenue Securities LLC boosted its position in shares of Insmed Incorporated (NASDAQ:INSM – Free Report) by 38.7% during the 1st quarter, Holdings Channel reports. The institutional investor owned 11,036 shares of the biopharmaceutical company’s stock after purchasing an additional 3,081 shares during the quarter. Park Avenue Securities LLC’s holdings in Insmed were worth $842,000 […] - 2025-06-13 05:18:50
Morgan Stanley Increases Insmed (NASDAQ:INSM) Price Target to $102.00
Insmed (NASDAQ:INSM – Get Free Report) had its price objective lifted by stock analysts at Morgan Stanley from $90.00 to $102.00 in a report released on Wednesday,Benzinga reports. The firm currently has an “overweight” rating on the biopharmaceutical company’s stock. Morgan Stanley’s target price suggests a potential upside of 5.28% from the stock’s previous close. […] - 2025-06-13 04:40:52
Insmed (NASDAQ:INSM) Stock Price Expected to Rise, Royal Bank of Canada Analyst Says
Insmed (NASDAQ:INSM – Get Free Report) had its target price raised by research analysts at Royal Bank of Canada from $99.00 to $106.00 in a report issued on Wednesday,Benzinga reports. The brokerage presently has an “outperform” rating on the biopharmaceutical company’s stock. Royal Bank of Canada’s price target would suggest a potential upside of 9.41% […] - 2025-06-13 04:40:51
Insmed (NASDAQ:INSM) Stock Price Expected to Rise, Mizuho Analyst Says
Insmed (NASDAQ:INSM – Get Free Report) had its price objective lifted by equities research analysts at Mizuho from $96.00 to $110.00 in a report issued on Wednesday,Benzinga reports. The firm presently has an “outperform” rating on the biopharmaceutical company’s stock. Mizuho’s price target points to a potential upside of 13.54% from the company’s current price. […] - 2025-06-13 04:40:49
Insmed (NASDAQ:INSM) Shares Up 4.5% Following Analyst Upgrade
Insmed Incorporated (NASDAQ:INSM – Get Free Report)’s stock price traded up 4.5% during trading on Wednesday after The Goldman Sachs Group raised their price target on the stock from $100.00 to $112.00. The Goldman Sachs Group currently has a buy rating on the stock. Insmed traded as high as $93.82 and last traded at $95.02. […] - 2025-06-13 02:17:01

iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) INSM holdings

DateNumber of INSM Shares HeldBase Market Value of INSM SharesLocal Market Value of INSM SharesChange in INSM Shares HeldChange in INSM Base ValueCurrent Price per INSM Share HeldPrevious Price per INSM Share Held
2025-11-11 (Tuesday)136,990USD 26,533,593INSM holding increased by 242472USD 26,533,5930USD 242,472 USD 193.69 USD 191.92
2025-11-10 (Monday)136,990INSM holding increased by 350USD 26,291,121INSM holding increased by 370513USD 26,291,121350USD 370,513 USD 191.92 USD 189.7
2025-11-07 (Friday)136,640USD 25,920,608INSM holding increased by 549293USD 25,920,6080USD 549,293 USD 189.7 USD 185.68
2025-11-06 (Thursday)136,640INSM holding increased by 350USD 25,371,315INSM holding decreased by -98560USD 25,371,315350USD -98,560 USD 185.68 USD 186.88
2025-11-05 (Wednesday)136,290USD 25,469,875INSM holding increased by 560152USD 25,469,8750USD 560,152 USD 186.88 USD 182.77
2025-11-04 (Tuesday)136,290INSM holding increased by 351USD 24,909,723INSM holding decreased by -406197USD 24,909,723351USD -406,197 USD 182.77 USD 186.23
2025-11-03 (Monday)135,939USD 25,315,920INSM holding decreased by -458114USD 25,315,9200USD -458,114 USD 186.23 USD 189.6
2025-10-31 (Friday)135,939USD 25,774,034INSM holding decreased by -628039USD 25,774,0340USD -628,039 USD 189.6 USD 194.22
2025-10-30 (Thursday)135,939INSM holding increased by 1755USD 26,402,073INSM holding increased by 4000054USD 26,402,0731,755USD 4,000,054 USD 194.22 USD 166.95
2025-10-29 (Wednesday)134,184INSM holding increased by 1015USD 22,402,019INSM holding increased by 390515USD 22,402,0191,015USD 390,515 USD 166.95 USD 165.29
2025-10-28 (Tuesday)133,169USD 22,011,504INSM holding increased by 169125USD 22,011,5040USD 169,125 USD 165.29 USD 164.02
2025-10-27 (Monday)133,169USD 21,842,379INSM holding increased by 580616USD 21,842,3790USD 580,616 USD 164.02 USD 159.66
Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of INSM by Blackrock for IE00BYXG2H39

Show aggregate share trades of INSM

DateActionQuantityMarket HighMarket LowLikely Trade PriceLikely Trade Value (Profit/Loss)Average Price previous trades
2025-11-10BUY350192.390185.690 186.360USD 65,226 93.01
2025-11-06BUY350188.440183.810 184.273USD 64,496 92.06
2025-11-04BUY351187.880182.580 183.110USD 64,272 91.11
2025-10-30BUY1,755194.700167.000 169.770USD 297,947 89.57
2025-10-29BUY1,015166.950167.780 167.697USD 170,212 89.17
2025-10-22SELL-1,404160.400166.620 165.998USD -233,061 87.23 Loss of -110,597 on sale
2025-10-20BUY702167.910168.220 168.189USD 118,069 86.37
2025-10-17BUY1,753165.760166.040 166.012USD 291,019 85.94
2025-10-15BUY2,792163.540165.760 165.538USD 462,182 85.51
2025-10-03BUY2,429157.160158.190 158.087USD 383,993 84.70
2025-10-02BUY347152.800152.850 152.845USD 53,037 84.32
2025-09-30BUY694144.010145.410 145.270USD 100,817 83.63
2025-09-26BUY694137.030137.040 137.039USD 95,105 83.00
2025-09-25BUY694135.590140.650 140.144USD 97,260 82.70
2025-09-24BUY10,866141.000145.560 145.104USD 1,576,700 82.36
2025-09-18BUY314145.860146.500 146.436USD 45,981 81.99
2025-09-17BUY948144.780146.500 146.328USD 138,719 81.63
2025-09-05SELL-316145.100145.190 145.181USD -45,877 80.49 Loss of -20,441 on sale
2025-08-20SELL-1,264129.450130.060 129.999USD -164,319 79.55 Loss of -63,767 on sale
2025-07-30BUY1,592105.180107.410 107.187USD 170,642 78.08
2025-07-17SELL-630104.170105.350 105.232USD -66,296 76.58 Loss of -18,053 on sale
2025-07-16BUY1,096104.590105.080 105.031USD 115,114 76.39
2025-07-11SELL-2,48898.18099.390 99.269USD -246,981 75.89 Loss of -58,172 on sale
2025-07-07BUY93396.95097.020 97.013USD 90,513 75.31
2025-07-02BUY17,10598.24098.380 98.366USD 1,682,550 74.99
2025-06-20BUY2,924102.680102.810 102.797USD 300,578 74.79
2025-06-13BUY28298.73099.650 99.558USD 28,075 73.86
2025-06-11BUY1,20097.98098.950 98.853USD 118,624 73.51
2025-06-04SELL-30073.69074.560 74.473USD -22,342 73.39 Loss of -323 on sale
2025-04-23BUY30070.80072.710 72.519USD 21,756 74.81
2025-04-10SELL-2,40064.81067.190 66.952USD -160,685 75.28 Profit of 19,979 on sale
2025-04-08SELL-30064.97070.560 70.001USD -21,000 75.48 Profit of 1,645 on sale
2025-04-07SELL-30068.09070.520 70.277USD -21,083 75.57 Profit of 1,588 on sale
2025-04-04SELL-1,50069.18072.500 72.168USD -108,252 75.64 Profit of 5,215 on sale
2025-04-01BUY2,59772.00075.650 75.285USD 195,515 75.72
2025-03-31SELL-88876.29076.700 76.659USD -68,073 75.71 Loss of -844 on sale
2025-03-21BUY4,85779.92081.190 81.063USD 393,723 75.50
2025-03-14SELL-4,48076.55077.410 77.324USD -346,412 75.34 Loss of -8,899 on sale
2025-03-07SELL-55874.89076.170 76.042USD -42,431 75.43 Loss of -343 on sale
2025-03-04SELL-28077.21078.410 78.290USD -21,921 75.37 Loss of -817 on sale
2025-02-25BUY56077.50081.670 81.253USD 45,502 75.10
2025-02-19SELL-27983.83083.890 83.884USD -23,404 74.58 Loss of -2,595 on sale
2025-02-13BUY83778.67079.690 79.588USD 66,615 74.17
2025-02-12BUY27979.60080.280 80.212USD 22,379 74.06
2025-02-11BUY1,11679.89080.010 79.998USD 89,278 73.94
2024-12-30SELL-6,12968.87069.600 69.527USD -426,131 72.36 Profit of 17,381 on sale
2024-11-18SELL-4,42566.61067.260 67.195USD -297,338 70.94 Profit of 16,559 on sale
2024-11-08SELL-29573.54073.640 73.630USD -21,721 70.81 Loss of -832 on sale
2024-10-21SELL-29572.28074.290 74.089USD -21,856 0.00 Loss of -21,856 on sale
Market high and low price is on the date.

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of INSM

DateShorted VolumeShort Exempt VolumeTotal Shares Traded% Shorted
2025-09-19172,5311,415480,68735.9%
2025-09-18192,4191,396488,53239.4%
2025-09-17258,254358657,58639.3%
2025-09-16234,877118631,37937.2%
2025-09-15281,7980849,08733.2%
2025-09-12276,8760792,54934.9%
2025-09-11232,7891,547706,71332.9%
2025-09-10298,194739767,29038.9%
2025-09-09285,0061607,09046.9%
2025-09-08226,229224654,28834.6%
2025-09-05325,826281,044,43831.2%
2025-09-04248,903665733,06334.0%
2025-09-03350,85401,100,91931.9%
2025-09-02978,5203,5282,123,85846.1%
2025-08-29391,48115838,63746.7%
2025-08-28307,99419,763681,03345.2%
2025-08-27359,4230988,38136.4%
2025-08-26309,0849862,40435.8%
2025-08-25328,52686915,12535.9%
2025-08-22499,36801,021,14648.9%
2025-08-21473,4691,317988,73147.9%
2025-08-20436,0533,929931,88346.8%
2025-08-19428,16601,016,55742.1%
2025-08-18562,7181,2681,332,87742.2%
2025-08-15736,274301,803,55640.8%
2025-08-141,023,9343202,229,62245.9%
2025-08-13722,47512,238,83432.3%
2025-08-121,753,6667013,484,21050.3%
2025-08-11511,65101,434,17635.7%
2025-08-08360,30601,213,66529.7%
2025-08-07435,1451861,629,36326.7%
2025-08-06541,4971,8141,567,24534.6%
2025-08-05557,3753,0531,406,78939.6%
2025-08-04510,869481,127,74445.3%
2025-08-01385,7081,1351,044,89536.9%
2025-07-31570,5882,5981,011,30656.4%
2025-07-30777,2961,4001,553,45750.0%
2025-07-29245,874242687,94135.7%
2025-07-28330,814146938,03835.3%
2025-07-25243,537471722,55733.7%
2025-07-24171,39818713,65624.0%
2025-07-23236,916636800,81829.6%
2025-07-22228,3820552,06741.4%
2025-07-21252,5300764,28933.0%
2025-07-18244,4971,210505,60848.4%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.